“February 18, 2002 Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Lab execs and pathologists should pay close attention to this fact: Internet use by Americans significantly increased again last year. The Commerce Department reported that. as of September, 143 million people in the U.S. were using the Internet. This is 54% of the population and represents an increase of 26% from one year earlier. E-mail is the most popular application. Of equal significance, Web use by Blacks, Mexicans, and rural residents rose by 33%, 36%, and 24%. This demonstrates that socio-economic barriers are not affecting access to the Internet. Because health is the number one use of the Internet, labs should have a strategy to address patients using the Web.


On January 22, Cerner Corporation announced that it had received ISO 9001: 2000 certification. With that accomplishment, it joins Siemens Medical Systems and Misys Healthcare Systems in achieving one of the various ISO certifications.


It’s an exciting new discovery in diagnostics. In a study involving 116 specimens, researchers used a unique test and correctly identified all 50 patients with ovarian cancer, including 18 with Stage 1 cancer, considered highly curable. Of the 66 patients who were negative for cancer, the test incorrectly identified five women as positive. What makes this test unique is that, unlike most assays which measure a single substance, this test evaluates five different proteins, which, if they appear in certain patterns, trigger a positive reading.


Researchers from the National Cancer Center, the FDA, and Correlogic Systems, Inc. of Bethesda, Maryland developed this test. A computer algorithm is used to evaluate the patterns of the five target proteins. THE DARK REPORT has long predicted that computer programs would be developed that would identify clinically useful diagnostic information from an analysis of multiple sets of lab test data. The software would search for patterns across a specific patient population and would then apply those clinically useful patterns to the test results of individual patients.


  • Where does a hard-working pathologist go after selling his clinical laboratory to one of the two blood brothers? Hawaii, of course! Alfred Lui, M.D., formerly President and CEO of Bio-Diagnostic Laboratories in Torrance (now owned by LabCorp), can now be found working several days per week in Honolulu as part of the pathology staff of Diagnostic Laboratories.
  • It was last fall when John Littleton retired from his position as National Sales Manager at Specialty Laboratories to return to the East Coast. But apparently “retirement” was not to his liking. Littleton has taken a position with USLabs and will manage its sales activities in the Northeast United States.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.